Homepage
PR Newswire
06-03-2011, 04:38 PM
(05-03-2011, 11:18 PM)mrEngineer Wrote: Interesting. I have a feeling that the counter will emerge in HK market soon.
I think this is highly likely. Based on its EPS of over 5 SG cents and its growing treatment capacity (and membrane technology). I think this company could easily trade at a much higher price elsewhere.
The Management has close ties to Singapore so I am surprised he is choosing to delist instead of dual-listing.
Disclaimer: Please feel free to correct any error in my post. I am not liable for anything. Do your own research and analysis. I do NOT give buy or sell calls and stock tips. Buy and sell at your risk. I am not a qualified financial adviser so I do not give any advice. The postings reflects my own personal thoughts which may or may not be accurate.